Jump to content

Global Health Medical Device Compendium/Home Phototherapy Unit

From Appropedia
Device data
Health topic Child mortality
Classification Treatment
Scope Commercialized
Manufacturer
location
Iran

Jaundice in newborns is an extremely common condition that can result in kernicterus (brain damage) or even death without medical treatment. Resource-limited areas often lack the equipment necessary to treat this condition with phototherapy. In addition, phototherapy systems are generally large so they cannot be transported, causing newborns to extend their stay in hospitals.

Detailed description of the solution

[edit | edit source]

The home phototherapy unit is a small, portable device that can treat jaundice in newborns at home. The light waves transform toxic bilirubin in the newborn’s blood into a safer product. This unit has a timer, cooling system, an alarm, four folding legs. It is transportable and can be easily used by any caregiver.

Designed by

[edit | edit source]
  • Designed by: Ehsan Dargazy
  • Manufacturer: Tosan Co.
  • Manufacturer location: Iran

When and where it was tested/implemented

[edit | edit source]

Iran

References

[edit | edit source]

Other internally generated reports

[edit | edit source]

Tosan Co. (2012). Home Phototherapy 027. Retrieved November 29, 2013 from here.

Externally generated reports

[edit | edit source]

Design to Improve Life. Home Phototherapy. Retrieved November 29, 2013 from here.

Maternova. (January 11, 2013). Home Phototherapy Unit. Retrieved November 29, 2013 from here.

[edit | edit source]

Copyright © 2012 Tosan Co.

Page data
SDG SDG03 Good health and well-being
Authors Lonny Grafman, Chris Waterguy, Emilio, Kathleen Sienko, Amir Sabet Sarvestani
License CC-BY-SA-3.0
Language English (en)
Related 0 subpages, 1 pages link here
Redirects Home Phototherapy Unit
Views 94 page views (analytics)
Created November 30, 2013 by Kelly Wojcik
Last edit September 10, 2026 by Felipe Schenone
Cookies help us deliver our services. By using our services, you agree to our use of cookies.